Merck Serono S.A.Geneva Switzerland
Company Description
The fertile minds at Merck Serono help people around the world combat infertility. One of the world's top biotechs, Merck Serono focuses on recombinant genetic engineering to develop drugs. The firm manufactures and markets therapies for neurological, metabolic, endocrinology, oncology, cardiovascular, and growth disorders, among others. It is a leader in reproductive health; flagship drug Gonal-F is a leading infertility product line. Other key products include beta interferon drug Rebif for the treatment of multiple sclerosis (MS) and colorectal and head/neck cancer treatment Erbitux. The company is German drugmaker
| 9, Chemin Des Mines | Phone: +41-22-414-3000 | http://www.merckserono.com |
| Geneva 1211 | Fax: +41-22-414-2179 | 
Map This Company |
| Switzerland |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Merck Serono S.A. Rankings
Executives
| 19 executives listed for Merck Serono S.A.'s Geneva, Switzerland location. | ||
| President | Stefan Oschmann | |
|---|---|---|
| COO | Belén Garijo | |
| EVP Global Business Unit CardioMetabolic Care and General Medicine; EVP Business Unit Emerging Markets | Franck Latrille | |
Financials
| Company Type | SubsidiaryHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 640 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Merck Serono S.A. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
